A STUDY TO COMPARE THE EFFECT OF AJAMODADI VATAKA WITH SIMHANADA GUGGULU IN AMAVATA (RHEUMATOID ARTHRITIS)

AN OPEN LABEL DOUBLE ARM PROSPECTIVE CLINICAL STUDY TO EVALUATE THE EFFECTIVENESS OF AJAMODADI VATAKA WITH SIMHANADA GUGGULU IN AMAVATA (RHEUMATOID ARTHRITIS)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/06/026212

Enrollment

120

Registered

2020-06-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

Intervention1: AJAMODADI VATAKA: AJAMODADI VATAKA 4GM TID AF FOR 30 DAYS Control Intervention1: SIMHANADA GUGGULU: SIMHANADA GUGGULU 1 GM TID AF FOR 30 DAYS

Eligibility

Inclusion criteria

Inclusion criteria: i. Duration of illness: less than 5 years. ii. Age: 17 years to 65 years. iii. Sex: Either gender.

Exclusion criteria

Exclusion criteria: i. Uncontrolled Diabetes mellitus, Hypertension ii. Patients of Rheumatoid arthritis who have developed deformities iii. Systemic arthritis (gout, tubercular arthritis, Systemic lupus erythematous, psoriatic arthritis) iv. Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
REDUCTION IN THE SIGNS AND SYMPTOMS OF AMAVATA (RHEUMATOID ARTHRITIS)Timepoint: 1ST DAY, 15TH DAY AND 30 TH DAY	—

Secondary

Measure	Time frame
REDUCTION IN ESR, RA, CRP, DAS 28 AND RAPID 3 SCORESTimepoint: 30 DAYS	—

Countries

India

Contacts

Public ContactDr Kirthiprakash Upadhyaya

SDM College of Ayurveda and Hospital, Hassan

sooryajadhav@gmail.com9886614116

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026